The economic impact of critical congenital heart disease to the health system and families in Colombia

Author:

Chamorro Velásquez Cindy LorenaORCID,Sandoval Reyes Nestor Fernando,Taborda Restrepo Alejandra,Romero Ducuara Sandra Vanessa,Domínguez Maria TeresaORCID,Troncoso Moreno Gloria Amparo,Cuevas Alejandra Fonseca,Aranguren Bello Hernan CamiloORCID,Bermúdez Hernadez Pablo Andres,Trujillo Pablo Sandoval,Dennis Rodolfo Jose,Londoño Trujillo Darío

Abstract

Background: Critical congenital heart disease (CCHD) make up a group of heart diseases present in newborns since the prenatal period and requiring early intervention through surgery or percutaneous interventions in the first year of life. Little is known about the societal economic impact associated with their care in low to middle income countries. We estimated direct medical costs, out-of-pocket expenditures and indirect costs of CCHD patients in Colombia. Methods: The methodology to estimate costs involved four stages: identification, measurement, and assessment of resources consumed, and total cost calculation. Regarding medical costs, hospital and ambulatory costs were estimated for the patient’s first year of life using clinical records of 73 patients and with thematic experts. A survey was carried out on 20 children´s caregivers to determine the out-of-pocket expenses and indirect costs. For this estimation, a descriptive analysis was made on the survey taking into account the reported salary. All costs are expressed in US dollars (2017 exchange rates). Results: The average direct medical hospital costs for CCHDs were $25,835 and the ambulatory costs reached $480. Indirect costs were $1,303 and out-of-pocket expenses were $2,058, which for families with an income lower than one monthly minimum wage (1 SMMLV) in 2017 correspond to $250. The impact on their budget was 57%. Conclusions: CCHDs represent an important economic impact both for the Colombian General Social Health System and for families. This study made it possible to estimate the costs that are not easily visible and thus quantified.

Funder

Departamento Administrativo de Ciencia, Tecnología e Innovación

Publisher

F1000 Research Ltd

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Critical congenital heart disease detection in the ANDES: Challenges and opportunities;International Journal of Cardiology Congenital Heart Disease;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3